This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Allergan, Inc.. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: Innovations by Elisabeth Rossi in Ocular Therapeutics
Introduction
Elisabeth Rossi is a prominent inventor based in Nice, France, known for her significant contributions to ocular therapeutics. With a total of three patents to her name, she has made remarkable advancements in the field of biocompatible microspheres for eye treatment.
Latest Patents
One of her latest patents is for intraocular biodegradable microspheres. These biocompatible microspheres can include an active agent and a biodegradable polymer that effectively facilitates the release of the active agent into the vitreous of the eye for an extended period. The therapeutic agent can be associated with a biodegradable polymer matrix, which can be made by crystallizing the active agent in the matrix. The resulting biodegradable microspheres can be placed into the eye to treat or reduce the occurrence of one or more ocular conditions. Another notable patent is for tyrosine kinase microspheres. These biocompatible intraocular microspheres include a tyrosine kinase inhibitor and a biodegradable polymer that facilitates the release of the inhibitor into the vitreous of the eye for an extended period. The therapeutic agents can be associated with a biodegradable polymer matrix that is substantially free of polyvinyl alcohol. These microspheres can also be placed into the eye to treat or reduce the occurrence of various ocular conditions.
Career Highlights
Elisabeth Rossi is currently employed at Allergan, Inc., where she continues to innovate and develop new therapeutic solutions for eye care. Her work has been instrumental in advancing the treatment options available for patients suffering from ocular conditions.
Collaborations
Elisabeth has collaborated with notable colleagues such as Patrick Michael Hughes and Christian Sarrazin, contributing to a dynamic and innovative work environment.
Conclusion
Elisabeth Rossi's contributions to ocular therapeutics through her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for new treatment options that can significantly improve patient outcomes.